Shun‐ichi Isa

1.7k total citations
43 papers, 1.3k citations indexed

About

Shun‐ichi Isa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Shun‐ichi Isa has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Shun‐ichi Isa's work include Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Diagnosis and Treatment (14 papers) and Lung Cancer Research Studies (11 papers). Shun‐ichi Isa is often cited by papers focused on Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Diagnosis and Treatment (14 papers) and Lung Cancer Research Studies (11 papers). Shun‐ichi Isa collaborates with scholars based in Japan, United States and Italy. Shun‐ichi Isa's co-authors include Tomoya Kawaguchi, Akihito Kubo, Akihiro Tamiya, Masahiko Ando, Hideo Saka, Minoru Takada, Shinji Atagi, Tomonori Hirashima, Motohiro Tamiya and Takayuki Shiroyama and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Shun‐ichi Isa

42 papers receiving 1.3k citations

Peers

Shun‐ichi Isa

PRM

ONCOL

SURGE

Michael L. Cheng United States

Gianluca Del Conte Italy

Seiichi Kakegawa Japan

Manlio Mencoboni Italy

J.J. Lafitte France

Claudio Martín Argentina

Christine K. Gause United States

Yihui Wen China

Jianjiao Ni China

A. Kooistra Netherlands

Michael L. Cheng United States

Shun‐ichi Isa

367 ×0.4

PRM

508 ×0.6

ONCOL

338 ×1.3

346 ×1.4

70 ×0.8

SURGE

Citations per year, relative to Shun‐ichi Isa Shun‐ichi Isa (= 1×) peers Michael L. Cheng

Countries citing papers authored by Shun‐ichi Isa

Since Specialization

Citations

This map shows the geographic impact of Shun‐ichi Isa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun‐ichi Isa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun‐ichi Isa more than expected).

Fields of papers citing papers by Shun‐ichi Isa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun‐ichi Isa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun‐ichi Isa. The network helps show where Shun‐ichi Isa may publish in the future.

Co-authorship network of co-authors of Shun‐ichi Isa

This figure shows the co-authorship network connecting the top 25 collaborators of Shun‐ichi Isa. A scholar is included among the top collaborators of Shun‐ichi Isa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun‐ichi Isa. Shun‐ichi Isa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tamiya, Akihiro, Daijiro Harada, Shun‐ichi Isa, et al.. (2024). Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung Cancer. 195. 107917–107917. 4 indexed citations

Taniguchi, Yoshihiko, Daijiro Harada, Shun‐ichi Isa, et al.. (2024). Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status. BMC Pulmonary Medicine. 24(1). 407–407.

Kaneda, Hiroyasu, Yasuhiro Koh, Akihiro Tamiya, et al.. (2022). The Impact of Estrogen Receptor Expression on Mutational Status in the Evolution of Non-Small Cell Lung Cancer. Clinical Lung Cancer. 24(2). 165–174. 2 indexed citations

Koh, Yasuhiro, Hiroyasu Kaneda, Kenji Sawa, et al.. (2020). Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan. BMJ Open. 10(9). e035615–e035615. 6 indexed citations

Tamiya, Akihiro, Shun‐ichi Isa, Yoshihiko Taniguchi, et al.. (2020). Prospective Observational Study of Treatment Resistance-related Gene Screening Using Plasma Circulating Tumor DNA in Third-generation EGFR-TKI Osimertinib Therapy (Elucidator). Clinical Lung Cancer. 22(3). e336–e341. 6 indexed citations

Nakao, Keiko, Shinji Kobuchi, Akihiro Tamiya, et al.. (2019). Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer. Scientific Reports. 9(1). 18202–18202. 24 indexed citations

Shiroyama, Takayuki, Hidekazu Suzuki, Motohiro Tamiya, et al.. (2018). Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung Cancer. Anticancer Research. 38(8). 4723–4729. 43 indexed citations

Tamiya, Akihiro, Motohiro Tamiya, Takashi Nishihara, et al.. (2017). OA08.05 Efficacy and Cerebrospinal Fluid Concentration of Afatinib in NSCLC Patients with EGFR Mutation Developing Leptomeningeal Carcinomatosis. Journal of Thoracic Oncology. 12(1). S273–S273. 6 indexed citations

Watanabe, Masaru, Tomoya Kawaguchi, Shun‐ichi Isa, et al.. (2017). Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR. EBioMedicine. 21. 86–93. 16 indexed citations

10.

Tamiya, Akihiro, Motohiro Tamiya, Takashi Nishihara, et al.. (2017). Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study. Anticancer Research. 37(8). 4177–4182. 70 indexed citations

11.

Nakahama, Kenji, Shun‐ichi Isa, Akihiro Tamiya, et al.. (2017). The Association Between Chemotherapy Immediately Before Nivolumab and Outcomes Thereafter. Anticancer Research. 37(10). 5885–5891. 10 indexed citations

12.

Mitsuoka, Shigeki, Tomoya Kawaguchi, Akihito Kubo, et al.. (2016). Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR. Expert Opinion on Pharmacotherapy. 17(2). 193–203. 2 indexed citations

13.

Watanabe, Masaru, Tomoya Kawaguchi, Shun‐ichi Isa, et al.. (2015). Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR. Clinical Cancer Research. 21(15). 3552–3560. 182 indexed citations

14.

Isa, Shun‐ichi, Satomi Yamamoto, Akihiro Tamiya, et al.. (2014). Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer. Oncology Letters. 9(2). 927–929. 7 indexed citations

15.

Kawaguchi, Tomoya, Masahiko Ando, Kazuhiro Asami, et al.. (2014). Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA). Journal of Clinical Oncology. 32(18). 1902–1908. 197 indexed citations

16.

Kawaguchi, Tomoya, Masahiko Ando, Norimasa Ito, et al.. (2013). Rationale and Design of the Japan Molecular Epidemiology for Lung Cancer Study. Clinical Lung Cancer. 14(5). 596–600. 3 indexed citations

17.

Tsujino, Kazuyuki, Takayasu Kurata, Satomi Yamamoto, et al.. (2013). Is Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy Beneficial for Patients with Locally Advanced Non–Small-Cell Lung Cancer?: A Pooled Analysis of the Literature. Journal of Thoracic Oncology. 8(9). 1181–1189. 75 indexed citations

18.

Isa, Shun‐ichi, Tomoya Kawaguchi, Satoshi Teramukai, et al.. (2009). Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer: Results from JMTO LC 0004. Journal of Thoracic Oncology. 4(9). 1104–1110. 48 indexed citations

19.

Tsujino, Kazuyuki, Tomoya Kawaguchi, Akihito Kubo, et al.. (2009). Response Rate Is Associated with Prolonged Survival in Patients with Advanced Non-small Cell Lung Cancer Treated with Gefitinib or Erlotinib. Journal of Thoracic Oncology. 4(8). 994–1001. 36 indexed citations

20.

Noguchi, Makoto, et al.. (2003). Induction of Hepatocyte Nuclear Factor 3γ Gene Expres- sion by the Extracellular Matrix Component from Fish Skin. Yonago acta medica. 46(4). 103–108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact